On September 17, 2024, the Board of Directors of Rhinebeck Bank, the wholly owned subsidiary of Rhinebeck Bancorp, Inc., provided notice of non-renewal to each of Michael J. Quinn, President and Chief Executive Officer, and Jamie J. Bloom, EVP, Chief Operating Officer & Chief Banking Officer, under each individual’s Amended and Restated Employment Agreement.
On September 17, 2024, the Board of Directors of Rhinebeck Bank, the wholly owned subsidiary of Rhinebeck Bancorp, Inc., provided notice of non-renewal to each of Michael J. Quinn, President and Chief Executive Officer, and Jamie J. Bloom, EVP, Chief Operating Officer & Chief Banking Officer, under each individual’s Amended and Restated Employment Agreement.
Departed
Hunter R. Greenlaw, Jr.
member of the board of directors
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2024-09-16
Filed
September 20, 2024, 7:59 PM ET
As a result, Mr. Greenlaw ceased to serve as a member of the Old Dominion Electric Cooperative board of directors on such date.
On September 17, 2024, Daniel N. Swisher Jr., a member of the Board of Directors (the “Board”) of Protagonist Therapeutics, Inc. (the “Company”) and a member of the Audit Committee of the Board, resigned from the Board, effective September 17, 2024.
Departed
Erik Mickelson
Chief Accounting Officer
Paragon 28, Inc.
Effective
2024-09-20
Filed
September 20, 2024, 7:59 PM ET
Erik Mickelson has stepped down as Chief Accounting Officer of Paragon 28, Inc.
Departed
Jay K. Varma
Executive Vice President and Chief Medical Officer
On September 19, 2024, Dr. Jay K. Varma began an indefinite leave of absence from his positions as Executive Vice President and Chief Medical Officer of SIGA Technologies, Inc. (the “Company”) and as a member of the Board of Directors of the Company.
On September 19, 2024, Dr. Jay K. Varma began an indefinite leave of absence from his positions as Executive Vice President and Chief Medical Officer of SIGA Technologies, Inc. (the “Company”) and as a member of the Board of Directors of the Company.
On September 16, 2024, Marie Myers, a member of the Board of Directors (the “Board”) of KLA Corporation (the “Company”), notified the Company that she will not stand for reelection to the Board at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”), and therefore her term as a director will end at the Annual Meeting.
Departed
L. Denise Williams
Chief People Officer
FIS ·
Fidelity National Information Services, Inc.
Effective
2024-12-31
Successor
Robert Toohey
Filed
September 20, 2024, 7:59 PM ET
Ms. Williams will continue to serve as the Company’s Chief People Officer through December 31, 2024.
Departed
(interim)
David Gaiero
interim principal financial officer and principal accounting officer
In connection with such appointment, David Gaiero, who was serving as the Company’s principal financial officer and principal accounting officer on an interim basis, ceased serving in such capacities as of the Effective Date.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
On September 16, 2024, Eric B. Staves, Vice President, Corporate Controller, informed CONMED Corporation (the “Company”) that, effective September 27, 2024, he plans to leave the Company to pursue an executive opportunity.
On September 16, 2024, Mark Richardson resigned as a director of SunHydrogen, Inc.
Departed
Nadine Watt
Director
Collective Audience, Inc.
Effective
2024-09-18
Successor
Peter Bordes
Filed
September 20, 2024, 7:59 PM ET
On September 18, 2024, Collective Audience, Inc. (the “Company”) effectuated the resignation of Ms. Nadine Watt, a member of the Board of Directors (the “Board”) pursuant to the provisions of that certain Voting Agreement, dated as of November 2, 2023, by and between the Company, Abri Ventures I, LLC (the “Sponsor”) and other parties thereto.
Departed
Raymond Cole
Chief Financial Officer
ECD Automotive Design, Inc.
Effective
2024-09-16
Successor
Benjamin Piggott
Filed
September 20, 2024, 7:59 PM ET
On September 16, 2024, ECD Automotive Design, Inc. (the “Company”) received the resignation of Mr. Raymond Cole as Chief Financial Officer of the Company effective immediately.
Departed
Benjamin Piggott
Chairman of the Board
ECD Automotive Design, Inc.
Effective
2024-09-16
Successor
Scott Wallace
Filed
September 20, 2024, 7:59 PM ET
Mr. Piggott and Thomas Humble both resigned from their positions as members of the Board.
Departed
Thomas Humble
Director
ECD Automotive Design, Inc.
Effective
2024-09-16
Filed
September 20, 2024, 7:59 PM ET
Mr. Piggott and Thomas Humble both resigned from their positions as members of the Board.
On September 20, 2024, Mr. Anand Ramakrishnan, an independent director of the board of directors (the “Board”) of the Company notified the Company that he resigned from the Board, effective September 20, 2024.
Departed
Anthony Arnerich
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
James Liken
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Elizabeth Weatherman
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Donald Spence
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Mary Beth Moynihan
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Joseph Army
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Lori Knowles
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Lance Berry
Director
VAPOTHERM INC
Effective
2024-09-20
Successor
Konstantin Poukalov
Filed
September 20, 2024, 7:59 PM ET
the following directors of the Company resigned and ceased to be directors of the Company as of the Effective Time: Joseph Army, Anthony Arnerich, Lance Berry, Lori Knowles, James Liken, Mary Beth Moynihan, Donald Spence and Elizabeth Weatherman.
Departed
Harrison W. Kelly III
Chief Operating Officer
SERVOTRONICS INC /DE/
Effective
2024-09-17
Filed
September 20, 2024, 7:59 PM ET
On September 17, 2024, Harrison W. Kelly III tendered his resignation as Chief Operating Officer of Servotronics, Inc. (the “Company”), to pursue other business opportunities.
On September 17, 2024, Yolande G. Piazza, a member of the Board of Directors (the “Board”) of H&R Block, Inc. (the “Company”), notified the Board of her decision to resign as a director of the Company effective immediately.
On September 16, 2024, Robert Krcmarov, a director of Coeur Mining, Inc. ("Coeur"), notified the Chairman of Coeur's Board of Directors (the "Board") of his resignation as a director, effective immediately, to take a professional position which does not allow for continued service on outside boards.
Heartland Express, Inc. (the “Company”) is deeply saddened to announce that director Mr. Michael J. Sullivan passed away on September 14, 2024.
Departed
Lynn Beall
Executive Vice President and Chief Operating Officer of Media Operations
TEGNA INC
Effective
2025-08-31
Filed
September 19, 2024, 7:59 PM ET
On September 16, 2024, the Board of Directors of TEGNA Inc. (the “Company”) determined that, in connection with a restructuring of the Company's operations, the position of Executive Vice President and Chief Operating Officer of Media Operations of the Company (“EVP/COO”) will be eliminated, which will result in the termination of employment without cause of Lynn Beall.
Mr. Jackson will succeed Dave Rush, who has served as President & Chief Executive Officer since November 2022 and is retiring after 25 years of dedicated service to the Company, effective November 6, 2024.
On September 19, 2024, the Company announced that Andrea Wasserman departed from her position as Chief Commercial Officer of the Company, effective September 16, 2024.
Michael Croatti, Executive Vice President, Operations, agreed to transition from his role as an Executive Officer of the Company effective as of November 30, 2024.
On September 16, 2024, Robert J. Levenson notified the Board of Directors (the “ Board ”) of Paycom Software, Inc. (the “ Company ”) of his retirement from the Board and all committees thereof, effective September 17, 2024.
On September 16, 2024, Christopher Ashton, Ph.D., provided notice of his resignation from the board of directors (the “Board”) of PepGen Inc. (the “Company”), effective as of September 30, 2024.
On September 13, 2024 Olya Massalitina gave notice of her decision to resign from her position as Chief Financial Officer of Destiny Media Technologies Inc. (the "Company"). Her resignation will be effective on October 1, 2024.
Dr. Ford Tamer, a member of the Board of Directors of Marvell Technology, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of September 15, 2024.
On September 18, 2024, the Company notified Matt Wiley, the Company’s Chief Commercial Officer, that, in connection with the Clinical Prioritization, his position was being eliminated.
On September 16, 2024, Dr. Brian Kotzin notified Rigel Pharmaceuticals, Inc. (“ Rigel ”) of his decision to resign as a member of the Board of Directors of Rigel (the “ Board ”) and from the committees on which he serves, effective September 16, 2024.
On September 17, 2024, Robby Chang was terminated as Chief Executive Officer and President for cause, with immediate effect, by the board of directors (the “ Board ”) of Gryphon Digital Mining, Inc. (the “ Company ”).
On September 16, 2024, Ilan Shiloah, an independent director serving on the board of directors (the “Board”) of Silexion Therapeutics Corp, a Cayman Islands exempted company (the “Company”), informed the Company that he has resigned from the Board, including from his membership on each of the committees of the Board— the audit committee, the compensation committee, and the corporate governance and nominating committee— effective immediately.
Effective May 10, 2024 (the “Effective Date”), pursuant to the terms of the Letter Agreement dated September 27, 2023, Scott White was terminated as the Chief Operating Officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.